ICOS and systemic lupus erythematosus: Other studies have also shown that ICOS+ T cells, which should also include DOCK8+ Tfh cells, are expanded in both the (NZBxNZW)F1 mouse model of SLE and human SLE patients, while blockade of this pathway ameliorated disease severity in a murine model of SLE [65,66].